Survey of the impact of COVID-19 on access to STBBI-related health services including harm reduction services in Canada

The Public Health Agency of Canada wants your help to better understand how the COVID-19 pandemic has affected access to services for the care and prevention of HIV, hepatitis C and other sexually transmitted and blood-borne infections (STBBI). We also want to know how access to drug treatment and harm reduction services (such as addictions counselling and needle distribution programs) have been affected.

Start typing and press Enter to search